Laurèl Rauschenbach

Jul 31, 2024 | nature.com | Celia Dobersalske |Laurèl Rauschenbach |Yichao Hua |Christoph Alexander Berliner |Anika Grüneboom |Dieter H. Heiland | +12 more

AbstractThe ecosystem of brain tumors is considered immunosuppressed, but our current knowledge may be incomplete. Here we analyzed clinical cell and tissue specimens derived from patients presenting with glioblastoma or nonmalignant intracranial disease to report that the cranial bone (CB) marrow, in juxtaposition to treatment-naive glioblastoma tumors, harbors active lymphoid populations at the time of initial diagnosis.

Jul 31, 2024 | nature.com | Celia Dobersalske |Laurèl Rauschenbach |Yichao Hua |Christoph Alexander Berliner |Anika Grüneboom |Dieter H. Heiland | +12 more

AbstractThe ecosystem of brain tumors is considered immunosuppressed, but our current knowledge may be incomplete. Here we analyzed clinical cell and tissue specimens derived from patients presenting with glioblastoma or nonmalignant intracranial disease to report that the cranial bone (CB) marrow, in juxtaposition to treatment-naive glioblastoma tumors, harbors active lymphoid populations at the time of initial diagnosis.

Feb 9, 2023 | nature.com | Laurèl Rauschenbach

AbstractThe purpose of this study was to investigate the functional outcome following surgical resection of cerebral cavernous malformations (CCM) in pediatric patients. We screened our institutional database of CCM patients treated between 2003 and 2021. Inclusion regarded individuals younger or equal than 18 years of age with complete clinical baseline characteristics, magnetic resonance imaging dataset, and postoperative follow-up time of at least three months.